Anisodine Hydromide/Procaine Hydrochloride

氢溴酸樟柳碱/盐酸普鲁卡因

Report date: 2025/07/22 15:55:26

Base Information

Drug NameAnisodine Hydromide/Procaine Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsAdrenergic receptor alpha-1 agonistsSodium channels blockers
TargetsMuscarinic acetylcholine receptorAdrenergic receptors alpha-1Sodium channels
Therapy Area/IndicationsChoroid DiseasesRetinal DiseasesOptic Neuropathy, Ischemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Anisodine HydromideProcaine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsChoroid DiseasesRetinal DiseasesOptic Neuropathy, Ischemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A